BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 3479814)

  • 21. [Ca 125 values in inflammatory adnexal disease and endometriosis].
    Sonsalla R; Kuss E; Zander J
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):499-500. PubMed ID: 3305148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of some tumor markers in differential diagnosis of ovarian tumor.
    Zakrzewska I; Borawska R; Poznański J; Maćkowiak B
    Rocz Akad Med Bialymst; 1999; 44():235-43. PubMed ID: 10697438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative differential diagnosis of solid and cystic gynecological tumours using one-dimensional ultrasonic technique.
    Pystynen P; Ylöstalo P; Järvinen PA
    Ann Chir Gynaecol Fenn; 1968; 57(2):153-6. PubMed ID: 5710639
    [No Abstract]   [Full Text] [Related]  

  • 24. [Imaging of benign ovarian tumors].
    Rouanet JP; Maubon A; Juhan V; Meny R; Salanon AP; Daclin PY
    J Radiol; 2000 Dec; 81(12 Suppl):1823-30. PubMed ID: 11173751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of CA-125 tumor marker determination in patients with ovarian carcinoma].
    Miladinović D; Paunović R; Paunković N
    Jugosl Ginekol Perinatol; 1989; 29(3-4):83-5. PubMed ID: 2601371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differential diagnosis between leiomyomata uteri and adenomyosis using CA 125 as a new tumor marker of ovarian carcinoma].
    Takahashi K; Kijima S; Yoshino K; Shibukawa T; Moriyama M; Iwanari O; Sawada K; Matsunaga I; Murao F; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):591-5. PubMed ID: 3857281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis].
    Nozawa S; Udagawa Y; Ito K; Nishimura H; Yakushiji M; Shiota M; Noda K; Yajima M; Ohkura H; Murae M
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):507-16. PubMed ID: 8129392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Benign ovarian tumor with ascites and high serum levels of CA125: report of 3 cases].
    Li HJ; Shen K; Lang JH; Wu M; Huang HF; Pan LY
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):147-9. PubMed ID: 12816688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum CA 125 levels in a group of nonhospitalized women: relevance for the early detection of ovarian cancer.
    Zurawski VR; Broderick SF; Pickens P; Knapp RC; Bast RC
    Obstet Gynecol; 1987 Apr; 69(4):606-11. PubMed ID: 2434895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormally high values of CA 125 and CA 19-9 in women with benign tumors.
    Nagata H; Takahashi K; Yamane Y; Yoshino K; Shibukawa T; Kitao M
    Gynecol Obstet Invest; 1989; 28(3):165-8. PubMed ID: 2680806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of monoclonal antibody OC 125 in gynecological oncology].
    Wu AR; Wang EY; Wang XX; Jia XH; Li L
    Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of persistent clear pelvic cysts diagnosed by ultrasonography.
    Hurwitz A; Yagel S; Zion I; Zakut D; Palti Z; Adoni A
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):320-2. PubMed ID: 3043288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A clinicopathologic study of ovarian tumors (author's transl)].
    Ueda G; Yamasaki M; Inoue M; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jan; 32(1):37-45. PubMed ID: 6263992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyst fluid CA 125 levels in ovarian epithelial neoplasms.
    Menczer J; Ben-Baruch G; Moran O; Lipitz S
    Obstet Gynecol; 1993 Jan; 81(1):25-8. PubMed ID: 8416456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical significance of the tumor marker CA-125 for the preoperative diagnosis and postoperative management of patients with malignant ovarian cancers].
    Sevelda P; Salzer H; Dittrich C; Spona J
    Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):769-73. PubMed ID: 3865860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of biochemical markers between benign and malignant ovarian cysts.
    Knight JA; Wu JT; Miya T; Knight DP
    Clin Physiol Biochem; 1986; 4(2):130-5. PubMed ID: 3516514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125].
    Sevelda P; Wagner G
    Wien Klin Wochenschr; 1987 Nov; 99(21):768-70. PubMed ID: 3480655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cytologic diagnosis of ovarian tumors by means of aspiration biopsy.
    Angstrom T; Kjellgren O; Bergman F
    Acta Cytol; 1972; 16(4):336-41. PubMed ID: 4504235
    [No Abstract]   [Full Text] [Related]  

  • 39. Surface (germinal) epithelium and related ovarian neoplasms.
    Blaustein A
    Pathol Annu; 1981; 16 Pt 1():247-94. PubMed ID: 7329732
    [No Abstract]   [Full Text] [Related]  

  • 40. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.